The C. elegans Hox gene
egl-5 is most similar, based on sequence analysis, to Abdominal-B . Consistent with its assignment into this paralog group,
egl-5 is expressed in the posterior region of the worm. Immuno-staining results have shown that in the hermaphrodite,
egl-5 is expressed in the hermaphrodite specific neuron, body wall muscle, posterior lateral microtubule neuron, PVC interneuron, the rectal epithelial cells K, F, B, U and the P12 neuroectoblast cell. 1 The two most posterior P cells are P11 and P12. The anterior products of their first division are both neuroblasts. P11.p fuses with the epidermal syncytium and P12.p divides again during late L1. The anterior division products, the epidermal cells P12.pa and P11.p are distinguishable by their distinct nuclear morphologies and positions. Previous genetic analysis indicates that P12 fate specification requires the synergistic action of the EGF and the Wnt signaling pathways. Reduction - or loss of function mutations in components of the EGF or the Wnt pathway result in partially penetrant P12 to P11 or P11 to P12 transformations. Double mutants of EGF and Wnt pathway components significantly enhance the frequency of transformation. P12 is not specified in an
egl-5(lf) mutant and overexpression of
egl-5 can rescue the loss of P12 specification phenotype of
let-23 mutants. 2 In order to understand how information from the EGF and Wnt pathway are integrated at a cis -regulatory level, we have undertaken an analysis of the
egl-5 promoter in collaboration with Scott Emmons to determine elements required for
egl-5 expression in P12. 3 Do the two pathways converge on the
egl-5 promoter or upstream of it? Beginning with a large promoter construct provided by Ferreira and Emmons, we have identified an approximately 1.3 kb. fragment of
egl-5 promoter sufficient to drive expression of a heterologous promoter in P12. This 1.3 kb fragment contains six sites of approximately 20-40 bp each which are conserved between C. elegans and C. briggsae . Specific deletion of at least two of these sites in certain combinations eliminates expression in P12, suggesting that these sites might represent P12 enhancers. Complementary to our cis regulatory analysis, we have been using EMS screens to identify, and are currently characterizing, potential trans-acting factors as well as other genes which may participate in signal integration. Ferreira et al .(1999) Dev. Biol. 207:215-228 Jiang and Sternberg (1998) Development 125:2337-2347